The medical device industry is undergoing a profound change in 2025, driven by advancements in generative AI and agentic AI. At the forefront of this revolution are players like NVIDIA (NVDA) , whose AI computing platforms are accelerating AI-powered medical applications and capturing investors’ attention.NVIDIA’s Clara platform, powered by generative AI, is enabling real-time medical imaging enhancements and predictive diagnostics. Additionally, NVIDIA’s BioNeMo, a generative AI model tailored for life sci ...